280 related articles for article (PubMed ID: 19948826)
1. Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo.
Ebrahem Q; Chaurasia SS; Vasanji A; Qi JH; Klenotic PA; Cutler A; Asosingh K; Erzurum S; Anand-Apte B
Am J Pathol; 2010 Jan; 176(1):496-503. PubMed ID: 19948826
[TBL] [Abstract][Full Text] [Related]
2. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
3. Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation.
Lee HS; Jun JH; Jung EH; Koo BA; Kim YS
Molecules; 2014 Aug; 19(8):12150-72. PubMed ID: 25123184
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.
Friehs I; Margossian RE; Moran AM; Cao-Danh H; Moses MA; del Nido PJ
Basic Res Cardiol; 2006 May; 101(3):204-13. PubMed ID: 16369727
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis.
Dean RA; Butler GS; Hamma-Kourbali Y; Delbé J; Brigstock DR; Courty J; Overall CM
Mol Cell Biol; 2007 Dec; 27(24):8454-65. PubMed ID: 17908800
[TBL] [Abstract][Full Text] [Related]
6. Regulation of matrix metalloproteinases 2 and 9 in corneal neovascularization.
Zhang J; Wang S; He Y; Yao B; Zhang Y
Chem Biol Drug Des; 2020 May; 95(5):485-492. PubMed ID: 31002472
[TBL] [Abstract][Full Text] [Related]
7. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells.
Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST
J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633
[TBL] [Abstract][Full Text] [Related]
8. Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2.
Wu Y; Dai J; Schmuckler NG; Bakdash N; Yoder MC; Overall CM; Colman RW
J Thromb Haemost; 2010 Jan; 8(1):185-93. PubMed ID: 19874467
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
Wang H; Keiser JA
Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II evokes angiogenic signals within skeletal muscle through co-ordinated effects on skeletal myocytes and endothelial cells.
Gorman JL; Liu ST; Slopack D; Shariati K; Hasanee A; Olenich S; Olfert IM; Haas TL
PLoS One; 2014; 9(1):e85537. PubMed ID: 24416421
[TBL] [Abstract][Full Text] [Related]
11. The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability.
Morbidelli L; Pyriochou A; Filippi S; Vasileiadis I; Roussos C; Zhou Z; Loutrari H; Waltenberger J; Stössel A; Giannis A; Ziche M; Papapetropoulos A
Am J Physiol Regul Integr Comp Physiol; 2010 Mar; 298(3):R824-32. PubMed ID: 20032260
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165.
Hashimoto G; Inoki I; Fujii Y; Aoki T; Ikeda E; Okada Y
J Biol Chem; 2002 Sep; 277(39):36288-95. PubMed ID: 12114504
[TBL] [Abstract][Full Text] [Related]
13. Up-Regulated Expression of Matrix Metalloproteinases in Endothelial Cells Mediates Platelet Microvesicle-Induced Angiogenesis.
Sun C; Feng SB; Cao ZW; Bei JJ; Chen Q; Zhao WB; Xu XJ; Zhou Z; Yu ZP; Hu HY
Cell Physiol Biochem; 2017; 41(6):2319-2332. PubMed ID: 28463834
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the blood-brain barrier integrity by pericytes via matrix metalloproteinases mediated activation of vascular endothelial growth factor in vitro.
Thanabalasundaram G; Pieper C; Lischper M; Galla HJ
Brain Res; 2010 Aug; 1347():1-10. PubMed ID: 20553880
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.
Kaliski A; Maggiorella L; Cengel KA; Mathe D; Rouffiac V; Opolon P; Lassau N; Bourhis J; Deutsch E
Mol Cancer Ther; 2005 Nov; 4(11):1717-28. PubMed ID: 16275993
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasion.
Belotti D; Calcagno C; Garofalo A; Caronia D; Riccardi E; Giavazzi R; Taraboletti G
Mol Cancer Res; 2008 Apr; 6(4):525-34. PubMed ID: 18403633
[TBL] [Abstract][Full Text] [Related]
18. Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma.
Hua C; Zhao G; Feng Y; Yuan H; Song H; Bie L
J Neurotrauma; 2016 Jan; 33(1):65-70. PubMed ID: 25646653
[TBL] [Abstract][Full Text] [Related]
19. Suppression of human microvascular endothelial cell invasion and morphogenesis with synthetic matrixin inhibitors. Targeting angiogenesis with MMP inhibitors.
Jia MC; Schwartz MA; Sang QA
Adv Exp Med Biol; 2000; 476():181-94. PubMed ID: 10949665
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells.
Park BC; Thapa D; Lee JS; Park SY; Kim JA
J Pharmacol Sci; 2009 Sep; 111(1):1-12. PubMed ID: 19763043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
